Champions Oncology, Inc.
CSBR · NASDAQ
4/30/2025 | 4/30/2024 | 4/30/2023 | 4/30/2022 | |
|---|---|---|---|---|
| Market Cap | $97,667 | $65,706 | $65,812 | $101,354 |
| - Cash | $9,785 | $2,618 | $10,118 | $9,007 |
| + Debt | $6,105 | $7,430 | $8,599 | $9,466 |
| Enterprise Value | $93,987 | $70,518 | $64,293 | $101,813 |
| Revenue | $56,944 | $50,155 | $53,870 | $49,109 |
| % Growth | 13.5% | -6.9% | 9.7% | – |
| Gross Profit | $26,915 | $20,754 | $24,338 | $25,477 |
| % Margin | 47.3% | 41.4% | 45.2% | 51.9% |
| EBITDA | $6,293 | -$5,413 | -$2,069 | $2,996 |
| % Margin | 11.1% | -10.8% | -3.8% | 6.1% |
| Net Income | $4,701 | -$7,276 | -$5,335 | $548 |
| % Margin | 8.3% | -14.5% | -9.9% | 1.1% |
| EPS Diluted | 0.33 | -0.54 | -0.39 | 0.039 |
| % Growth | 161.1% | -38.5% | -1,107.8% | – |
| Operating Cash Flow | $7,386 | -$6,137 | $3,955 | $6,497 |
| Capital Expenditures | -$389 | -$836 | -$2,872 | -$2,384 |
| Free Cash Flow | $6,997 | -$6,973 | $1,083 | $4,113 |